Thank you.
Since the audit was done for these years in question, there have been two tranches of investment in the health product and the food regulatory regime. One was in 2003, and it focused on improving product review times. Canada had fallen way behind international standards on realistic review times for new products. So there was an investment made in 2003.
In 2005 a second series of investments dealing with drug safety issues was made. As the deputy's mentioned, that was post-Vioxx. The concerns at that time were inspections, safety monitoring, and so on. So in fact there was considerable discussion within the department on the kinds of things we needed to move forward on in those two years. There were new investments that came forward that are actually multi-year in nature, so that funding for these areas increased this year, and it will increase again in 2007-08.